Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone vs. Sertraline and Haloperidol for psychotic depression
NCT00340379Phase 3Completed
- Sponsor
- Duke University
- Start
- Apr 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of ziprasidone (2 arms), sponsored by Duke University. Primary endpoints: 21 Item Hamilton Depression Rating Scale at 12 weeks, Clinical Global Impression Improvement Scale at 12 weeks and 1 more. Started Apr 2003; status: completed.
02
Drugs
ziprasidone
Beyond the preview
Go deeper on NCT00340379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00340379.